Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP for Chronic Tympanic Membrane Perforation
NCT03837665Phase 2Terminated
- Sponsor
- University of Kansas Medical Center
- Start
- May 2018
- Primary completion
- Oct 2019
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
A Phase 2 trial of autologous platelet-rich plasma in tympanic membrane perforation, sponsored by University of Kansas Medical Center. Started May 2018; status: terminated.
02
Drugs
autologous platelet-rich plasma
03
Conditions
tympanic membrane perforation
Beyond the preview
Go deeper on NCT03837665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03837665.